Ligand Pharmaceuticals Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	2,493,724	2,153,312	2,146,357	2,735,583	2,056,374	1,292,013	Upgrade
Revenue Growth (YoY)	12.74%	0.32%	-21.54%	33.03%	59.16%	-6.18%	Upgrade
Cost of Revenue	2,414,766	2,078,517	2,070,026	2,647,321	1,949,750	1,229,101	Upgrade
Gross Profit	78,958	74,795	76,331	88,262	106,624	62,912	Upgrade
Selling, General & Admin	70,529	71,232	72,602	72,391	68,845	60,707	Upgrade
Operating Expenses	70,529	71,232	72,602	72,391	68,845	60,707	Upgrade
Operating Income	8,429	3,563	3,728	15,871	37,779	2,205	Upgrade
Interest Expense	-95.19	-7.53	-18.49	-328.15	-633.85	-	Upgrade
Interest & Investment Income	2,159	1,194	1,876	1,329	1,575	2,287	Upgrade
Other Non Operating Income (Expenses)	10,242	8,210	4,760	5,481	7,387	6,551	Upgrade
Pretax Income	20,735	12,959	10,346	22,353	46,107	11,043	Upgrade
Income Tax Expense	4,596	3,056	4,018	4,507	9,340	2,249	Upgrade
Net Income	16,139	9,903	6,328	17,846	36,766	8,794	Upgrade
Net Income to Common	16,139	9,903	6,328	17,846	36,766	8,794	Upgrade
Net Income Growth	51.15%	56.49%	-64.54%	-51.46%	318.10%	-27.81%	Upgrade
Shares Outstanding (Basic)	12	12	12	-	12	-	Upgrade
Shares Outstanding (Diluted)	12	12	12	-	12	-	Upgrade
EPS (Basic)	1344.88	825.25	527.34	-	3063.87	-	Upgrade
EPS (Diluted)	1344.88	825.25	527.34	-	3063.87	-	Upgrade
EPS Growth	51.15%	56.49%	-	-	-	-	Upgrade
Free Cash Flow	50,551	26,884	37,186	-6,274	15,345	26,273	Upgrade
Free Cash Flow Per Share	4212.60	2240.33	3098.79	-	1278.73	-	Upgrade
Dividend Per Share	700.000	700.000	800.000	-	1700.000	700.000	Upgrade
Dividend Growth	-12.50%	-12.50%	-	-	142.86%	-	Upgrade
Gross Margin	3.17%	3.47%	3.56%	3.23%	5.18%	4.87%	Upgrade
Operating Margin	0.34%	0.17%	0.17%	0.58%	1.84%	0.17%	Upgrade
Profit Margin	0.65%	0.46%	0.29%	0.65%	1.79%	0.68%	Upgrade
Free Cash Flow Margin	2.03%	1.25%	1.73%	-0.23%	0.75%	2.03%	Upgrade
EBITDA	10,335	6,480	7,110	19,232	41,118	5,821	Upgrade
EBITDA Margin	0.41%	0.30%	0.33%	0.70%	2.00%	0.45%	Upgrade
D&A For EBITDA	1,906	2,917	3,382	3,361	3,339	3,616	Upgrade
EBIT	8,429	3,563	3,728	15,871	37,779	2,205	Upgrade
EBIT Margin	0.34%	0.17%	0.17%	0.58%	1.84%	0.17%	Upgrade
Effective Tax Rate	22.17%	23.58%	38.83%	20.16%	20.26%	20.37%	Upgrade
Revenue as Reported	2,493,724	2,153,312	2,146,357	2,735,583	2,056,374	1,292,013	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.